title: Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling.
abstract: Quantitative changes in cytochrome P450 (CYP) proteins involved in drug metabolism as a consequence of drug treatment are important parameters in predicting the fates and pharmacological consequences of xenobiotics and drugs. In this study we undertook comparative P450 proteomics using liver from control and 1,4-bis-2-(3,5-dichloropyridyloxybenzene) (TCPOBOP)-dosed mice. The method involved separation of microsomal proteins by SDS-PAGE, trypsin digestion, and postdigest 18O/16O labeling followed by nano-LC-MS/MS for peptide identification and LC-MS for relative quantification. Seventeen P450 proteins were identified from mouse liver of which 16 yielded data sufficient for relative quantification. All the P450s detected were unambiguously identified except the highly homologous CYP2A4/2A5. With the exception of CYP2A12, -2D10, and -2F2, the levels of all the P450s quantified were affected by treatment with TCPOBOP (3 mg/kg). CYP1A2, -2A4/5, -2B10, -2B20, -2C29, -2C37, -2C38, -3A11, and -39A1 were up-regulated, and CYP2C40, -2E1, -3A41, and -27A1 down-regulated. The response of CYP2B20 to stimulation has not been distinguished previously from that of CYP2B10 because of the poor discrimination between these two proteins (they share 87% sequence identity). Differential response to chemical stimulation by closely related members of the CYP2C subfamily was also observed.
authors.affiliation: The School of Pharmacy, University of London, London WC1N 1AX, United Kingdom.
authors.forename: Catherine S
authors.initials: CS
authors.lastname: Lane
authors.forename: Yuqin
authors.initials: Y
authors.lastname: Wang
authors.forename: Richard
authors.initials: R
authors.lastname: Betts
authors.forename: William J
authors.initials: WJ
authors.lastname: Griffiths
authors.forename: Laurence H
authors.initials: LH
authors.lastname: Patterson
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis* / Q000737:chemistry; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006801:Humans; D007553:Isotope Labeling; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D013058:Mass Spectrometry; D051379:Mice; D008819:Mice, Nude; D008862:Microsomes, Liver / Q000737:chemistry / Q000187:drug effects; D008969:Molecular Sequence Data; D010103:Oxygen Isotopes; D010455:Peptides / Q000032:analysis / Q000737:chemistry; D040901:Proteomics; D011725:Pyridines / Q000494:pharmacology; D011994:Recombinant Proteins / Q000032:analysis
chemical_list: D010103:Oxygen Isotopes; D010455:Peptides; D011725:Pyridines; D011994:Recombinant Proteins; C028474:1,4-bis(2-(3,5-dichloropyridyloxy))benzene; D003577:Cytochrome P-450 Enzyme System